Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

The Unique Appeal of Physical Gold ETFs in Today’s Market

Andreas Sommer by Andreas Sommer
September 15, 2025
in Commodities, ETF, Gold & Precious Metals
0
VanEck Merk Gold Trust Stock
0
SHARES
144
VIEWS
Share on FacebookShare on Twitter

Gold is reasserting its traditional role as a premier safe-haven asset during a period of significant economic uncertainty. A combination of anticipated interest rate cuts from the U.S. Federal Reserve, persistent inflationary pressures, and a softening U.S. dollar has propelled the precious metal toward record price levels. This favorable environment has drawn investor focus to exchange-traded funds offering direct exposure, notably the VanEck Merk Gold Trust (OUNZ), which distinguishes itself through a key structural feature.

Direct Access to Physical Metal

The VanEck Merk Gold Trust carves out a unique position in the marketplace with its distinctive physical redemption right. This provision allows shareholders to convert their ETF holdings into tangible gold, taking delivery in the form of London Good Delivery bars, one-ounce coins, or ten-ounce bars. This direct link to the underlying physical asset provides a level of security and tangible ownership that is highly valued by a specific segment of gold investors.

The trust’s structure is designed for transparency and security. It holds 100% allocated physical gold bullion—currently totaling approximately 543,756 ounces. Each share of the ETF represents a precise claim on 0.00963186 troy ounces of fine gold. All bullion is stored in segregated, audited vaults under the custody of JPMorgan Chase Bank, N.A., providing investors with confidence in the asset’s safety and authenticity.

Capitalizing on Gold’s Momentum

The trust’s performance metrics clearly reflect the powerful rally in gold prices. Its recent returns demonstrate strong alignment with the appreciating metal:
* 1-Week Gain: +1.33%
* 1-Month Gain: +8.47%
* Year-to-Date Return: +37.39%
* 1-Year Return: +40.70%

Should investors sell immediately? Or is it worth buying VanEck Merk Gold Trust?

Trading activity underscores the growing interest in the fund. Over the past three months, average daily trading volume has reached 870,000 shares. Furthermore, the trust has witnessed substantial net inflows, attracting an additional +$314.44 million in assets under management during the same three-month period.

Evaluating the Value Proposition

When measured against the massive scale of competitors like the SPDR Gold Shares (GLD) and the iShares Gold Trust (IAU), OUNZ’s primary advantage is its unique delivery feature. This leads investors to a central question: does this specific functionality justify its cost? The fund’s expense ratio is set at 0.25%, placing it in the mid-range among physically-backed gold ETFs.

The strategy of holding purely physical gold, with no use of derivatives, effectively eliminates counterparty risk. However, this also means the trust’s performance is exclusively tied to the spot price of gold. Investors receive no dividend income and benefit from no portfolio diversification—this is a pure-play investment in the precious metal.

Ultimately, the justification for the slightly higher cost hinges on an investor’s individual needs. For those who prioritize the option of taking direct physical possession of their investment, the value is clear-cut. For others seeking a more conventional, cost-efficient ETF vehicle, the decision requires more careful consideration.

Ad

VanEck Merk Gold Trust Stock: Buy or Sell?! New VanEck Merk Gold Trust Analysis from February 7 delivers the answer:

The latest VanEck Merk Gold Trust figures speak for themselves: Urgent action needed for VanEck Merk Gold Trust investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

VanEck Merk Gold Trust: Buy or sell? Read more here...

Tags: VanEck Merk Gold Trust
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Schnitzer Steel Industries Stock
Analysis

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

February 6, 2026
Lynas Stock
Asian Markets

Leadership Transition Looms for Key Rare Earths Producer

February 6, 2026
Luxor Industrialration Stock
Commodities

Industrial Timber Sector Eyes a Path to Stability

February 6, 2026
Next Post
Caterpillar Stock

Caterpillar Faces Mounting Tariff Pressures as Margins Contract

Exxon Mobil Stock

ExxonMobil's Dual-Pronged Strategy: Balancing Legacy Oil with Next-Generation Tech

NASDAQ 100 Stock

Tech-Heavy Nasdaq 100 Defies Market Weakness to Seal Record Close

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com